Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: WHICH IS BETTER!

WHICH IS BETTER!

posted on May 07, 2009 03:14PM

A totally dead 336 patent or one thats still in play with another re-x. I go with the second choice for now. You have the German validation. and the possability of a favorable out come of 336 here in the USA. TPL can still get some weak hands to buy the MMP. Like CLINT asked do you feel lucky punk well do you! The MMP is not dead yet.

So far the competition has been firing magnums at us will we shot back with BB guns. I never thought TPL was up to the task. JMHO

GLTA

Share
New Message
Please login to post a reply